Additionally, we aimed to test the hypothesis that leukocytes are one of the primary sources of PSP, YKL-40, and PCT, as well as the possibility that anti-thymocyte globulin (ATG) treatment could induce biomarker production. This evidence concerns the gene CHI3L1 and supranuclear palsy, progressive, 1.